406 related articles for article (PubMed ID: 16540559)
1. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559
[TBL] [Abstract][Full Text] [Related]
2. Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Timoshanko JR; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2005 Jul; 16(7):2012-22. PubMed ID: 15944341
[TBL] [Abstract][Full Text] [Related]
3. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis.
Tipping PG; Kitching AR; Huang XR; Mutch DA; Holdsworth SR
Eur J Immunol; 1997 Feb; 27(2):530-7. PubMed ID: 9045927
[TBL] [Abstract][Full Text] [Related]
4. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis.
Odobasic D; Kitching AR; Semple TJ; Holdsworth SR
J Am Soc Nephrol; 2007 Mar; 18(3):760-70. PubMed ID: 17267745
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis.
Phoon RK; Kitching AR; Jones LK; Holdsworth SR
Nephrology (Carlton); 2009 Oct; 14(7):650-7. PubMed ID: 19796023
[TBL] [Abstract][Full Text] [Related]
6. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis.
Kitching AR; Tipping PG; Timoshanko JR; Holdsworth SR
Kidney Int; 2000 Feb; 57(2):518-25. PubMed ID: 10652028
[TBL] [Abstract][Full Text] [Related]
7. CD80 and CD86 costimulatory molecules regulate crescentic glomerulonephritis by different mechanisms.
Odobasic D; Kitching AR; Tipping PG; Holdsworth SR
Kidney Int; 2005 Aug; 68(2):584-94. PubMed ID: 16014035
[TBL] [Abstract][Full Text] [Related]
8. Th1 cytokine responses fail to effectively control Chlamydia lung infection in ICOS ligand knockout mice.
Kadkhoda K; Wang S; Joyee AG; Fan Y; Yang J; Yang X
J Immunol; 2010 Apr; 184(7):3780-8. PubMed ID: 20190137
[TBL] [Abstract][Full Text] [Related]
9. A pathogenetic role for mast cells in experimental crescentic glomerulonephritis.
Timoshanko JR; Kitching AR; Semple TJ; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2006 Jan; 17(1):150-9. PubMed ID: 16319187
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis in progressive crescentic glomerulonephritis.
Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
[TBL] [Abstract][Full Text] [Related]
11. T cells in crescentic glomerulonephritis.
Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2006 May; 17(5):1253-63. PubMed ID: 16624930
[TBL] [Abstract][Full Text] [Related]
12. Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy.
Bellinghausen I; Klostermann B; Böttcher I; Knop J; Saloga J
Immunology; 2004 May; 112(1):80-6. PubMed ID: 15096187
[TBL] [Abstract][Full Text] [Related]
13. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.
Wolf D; Hochegger K; Wolf AM; Rumpold HF; Gastl G; Tilg H; Mayer G; Gunsilius E; Rosenkranz AR
J Am Soc Nephrol; 2005 May; 16(5):1360-70. PubMed ID: 15788479
[TBL] [Abstract][Full Text] [Related]
14. IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment.
Kitching AR; Turner AL; Wilson GR; Semple T; Odobasic D; Timoshanko JR; O'Sullivan KM; Tipping PG; Takeda K; Akira S; Holdsworth SR
J Am Soc Nephrol; 2005 Jul; 16(7):2023-33. PubMed ID: 15888563
[TBL] [Abstract][Full Text] [Related]
15. Only therapeutic ICOS:ICOSL blockade alleviates acute graft versus host disease.
Mollweide A; Staege MS; Hoeschen C; Hideo Y; Burdach S; Richter GH
Klin Padiatr; 2009; 221(6):344-50. PubMed ID: 19890785
[TBL] [Abstract][Full Text] [Related]
16. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats.
Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T
Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997
[TBL] [Abstract][Full Text] [Related]
17. Effects of double blockade of CD28 and inducible-costimulator signaling on anti-glomerular basement membrane glomerulonephritis.
Okano K; Nitta K; Ogawa S; Horita S; Habiro K; Nihei H; Abe R
J Lab Clin Med; 2004 Oct; 144(4):183-92. PubMed ID: 15514586
[TBL] [Abstract][Full Text] [Related]
18. Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis.
Frey O; Meisel J; Hutloff A; Bonhagen K; Bruns L; Kroczek RA; Morawietz L; Kamradt T
Ann Rheum Dis; 2010 Aug; 69(8):1495-501. PubMed ID: 20498202
[TBL] [Abstract][Full Text] [Related]
19. OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis.
Odobasic D; Ruth AJ; Oudin V; Kitching AR; Holdsworth SR
Nephrol Dial Transplant; 2019 Mar; 34(3):429-441. PubMed ID: 29939347
[TBL] [Abstract][Full Text] [Related]
20. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Kwan RY; Odobasic D; Ooi JD; Timoshanko JR; Hickey MJ; Holdsworth SR
J Am Soc Nephrol; 2006 Jul; 17(7):1940-9. PubMed ID: 16769746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
